Edward Nash
Stock Analyst at Canaccord Genuity
(1.84)
# 1274
Out of 5,346 analysts
106
Total ratings
32.00%
Success rate
31.09%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MDGL Madrigal Pharmaceuti... | Maintains: Strong Buy | 394 420 | 269.08 | 56.09% | 9 | May 2, 2025 | |
CLDX Celldex Therapeutics | Initiates Coverage On: Buy | 64 | 19.82 | 222.91% | 1 | Apr 28, 2025 | |
TVTX Travere Therapeutics | Maintains: Strong Buy | 45 47 | 15.41 | 205% | 10 | Apr 10, 2025 | |
CORT Corcept Therapeutics | Maintains: Strong Buy | 130 142 | 77.65 | 82.87% | 7 | Apr 1, 2025 | |
RANI Rani Therapeutics Hl... | Maintains: Buy | 9 9 | 0.58 | 1451.72% | 2 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 44 72 | 77.44 | -7.02% | 9 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 4 | 1.37 | 191.97% | 2 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 56 73 | 48.1 | 51.77% | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 89 | 37.67 | 136.26% | 1 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 15 14 | 1.81 | 673.48% | 6 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 6 8 | 1.23 | 550.41% | 3 | May 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 12 20 | 3.39 | 489.97% | 2 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 68 66 | n/a | n/a | 2 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 19 | n/a | n/a | 9 | Sep 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 8 | 2.6 | 207.69% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 71 48 | n/a | n/a | 3 | Jun 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 17 | 4.16 | 308.65% | 2 | May 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 3 2 | 2.23 | -10.31% | 4 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 17 | n/a | n/a | 2 | Jan 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 900 180 | 1.44 | 12400% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 52 | n/a | n/a | 2 | Aug 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 12 | n/a | n/a | 1 | Apr 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 19 1 | n/a | n/a | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 80 82 | 35.06 | 133.88% | 5 | Jun 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 120 80 | 2.27 | 3424.23% | 3 | Sep 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 10 3 | n/a | n/a | 1 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 20 | n/a | n/a | 1 | Oct 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 48 | 14.94 | 221.29% | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 650 | 6.16 | 10451.95% | 1 | Nov 8, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 150 0 | n/a | n/a | 3 | Sep 22, 2017 |